An MR-based brain template and atlas for optical projection tomography and light sheet fluorescence microscopy in neuroscience

Front Neurosci. 2024 Mar 27:18:1328815. doi: 10.3389/fnins.2024.1328815. eCollection 2024.

Abstract

Introduction: Optical Projection Tomography (OPT) and light sheet fluorescence microscopy (LSFM) are high resolution optical imaging techniques, ideally suited for ex vivo 3D whole mouse brain imaging. Although they exhibit high specificity for their targets, the anatomical detail provided by tissue autofluorescence remains limited.

Methods: T1-weighted images were acquired from 19 BABB or DBE cleared brains to create an MR template using serial longitudinal registration. Afterwards, fluorescent OPT and LSFM images were coregistered/normalized to the MR template to create fusion images.

Results: Volumetric calculations revealed a significant difference between BABB and DBE cleared brains, leading to develop two optimized templates, with associated tissue priors and brain atlas, for BABB (OCUM) and DBE (iOCUM). By creating fusion images, we identified virus infected brain regions, mapped dopamine transporter and translocator protein expression, and traced innervation from the eye along the optic tract to the thalamus and superior colliculus using cholera toxin B. Fusion images allowed for precise anatomical identification of fluorescent signal in the detailed anatomical context provided by MR.

Discussion: The possibility to anatomically map fluorescent signals on magnetic resonance (MR) images, widely used in clinical and preclinical neuroscience, would greatly benefit applications of optical imaging of mouse brain. These specific MR templates for cleared brains enable a broad range of neuroscientific applications integrating 3D optical brain imaging.

Keywords: LSFM; MRI; OPT; brain template; mesoscopic imaging; neuroimaging.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The research leading to this publication has received funding from the Umeå University Medical Faculty (DM and UA), the Kempe Foundations (UA), the Swedish Research Council (2020-06224 and 2018-05851 to AÖ and 2020-02300 to P-OB), the Laboratory for Molecular Infection Medicine Sweden (MIMS) (AÖ), the Novo Nordisk Foundation (MV and P-OB) and the Family Erling Persson Foundation (P-OB). SW, is the holder of a Marie Curie Actions postdoctoral fellowship funded by the European Commission. NC is the holder of a stipend from the MIMS Excellence by Choice Postdoctoral Program, funded by the Knut and Alice Wallenberg Foundation (KAW2015.0284).